PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 170.00
+2.00 (1.19%)
Aug 27, 2026, 1:36 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 6.21 billion as of August 26, 2026. Its market cap has decreased by -6.96% in one year.
Market Cap
6.21B
Enterprise Value
3.88B
Revenue
737.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
170.00
ChartMarket Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 6.21B, a decrease of -65.19%. That is a compound annual growth rate of -38.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 6.21B | 7.83% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 7.36B |
| MEDINET | 7.07B |
| CellSource | 6.89B |
| ADR Biomedical Holdings | 6.88B |
| Chiome Bioscience | 6.63B |
| Noile-Immune Biotech | 6.42B |
| Soiken Holdings | 5.86B |
| Chordia Therapeutics | 5.64B |